Keyword "SEMAX" found in the following publications:

SELANK AND SEMAX AS POTENTIAL HEPATOPROTECTORS IN MEDICAL TREATMENT OF TUBERCULOSIS
Introduction: Drug-induced hepatitis is common in clinical practice. This problem is particularly relevant in the treatment of tuberculous infection, because ...
Abstract | Full text (PDF)
CORRECTION OF HYPERTENSIVE RETINAL CHANGES IN RATS WITH SEMAX
Background: Currently, there are no drugs for the specific treatment of hypertensive retinal changes. The main therapy is for ...
Abstract | Full text (PDF)
TREATMENT OF HEPATITIS INDUCED BY ANTI-TUBERCULOSIS DRUGS (EXPERIMENTAL RESEARCH)
&NBSP;
Introduction: Tuberculosis is a widely spread infection. While treating patients for it, they are given simultaneously and for a long ...
Abstract | Full text (PDF)

Research Results in Biomedicine is included in the scientific database of the RINTs (license agreement No. 765-12/2014 dated 08.12.2014).

The journal is included in the list of peer-reviewed scientific publications recommended by the Higher Attestation Commission

The journal is indexed by the following scientific databases and platforms

Research Results in Biomedicine (ISSN 2658-6533)

The journal materials and website are licensed under Creative Commons «Attribution» 4.0 International.

The Founder: Federal State Autonomous Educational Institution of Higher Education "Belgorod National Research University"The Founder’s address: 85 Pobedy Street, Belgorod, the Belgorod region, 308015, Russia

The Publisher: Federal State Autonomous Educational Institution of HigherEducation "Belgorod National Research University" The Founder’s address:85 Pobedy Street, Belgorod, the Belgorod region, 308015, Russia

Editors Office: chief editor Mikhail I. Churnosov, e-mail: RR_MedPharm@bsu.edu.ru, phone: +7 (4722) 30-14-03.

Regulations on the Journal

Certificate

Have questions?
You can write to us:

✉ Content manager

✉ Site administration

✉ Executive Secretary